Oral Extended-Release Formulations

Pharmaceutical Manufacturing Handbook: Production and Processes

Volumn , Issue , 2007, Pages 1191-1222

  Larsson, Anette ^a   Abrahmsén Alami, Susanna ^b   Juppo, Anne ^c  

^a CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Hydrophilic matrix tablets; Insoluble matrix tablets and lipid or polymer based excipient; Oral extended release formulations

Indexed keywords

EID: 84889790372     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470259818.ch30     Document Type: Chapter

References (149)

1. Malinowski, H. J., and Marroum, P. J. (1999), Encyclopedia of Controlled Drug Delivery, vols. 1 and 2, Food and Drug Administration Requirements for Controlled Release Products, John Wiley & Sons, New York, vol. 1, pp. 381-395.
2. Aulton, M. E. (2002), Pharmaceutics: The Science of Dosage Form Design, Churchill Livingstone, Hartcourt Publisher, Edinburgh.
3. Marroum, P. J. (1997), Bioavialability/Bioequivalence for Oral Release Producs, Controlled Release Drug Delivery Systems. Paper presented at the 5th Int. Symp. Drug Del., East Brunswick, NJ, May 15-17.
4. SCHOLAR, SciFinder (2006), American Chemical Society, Washington, DC.
5. Yamanaka, K., Yamamoto, H., Kawamura, Y., and Ito, S. (1954), Pyrimidine pencillin, U.S. Patent 2,681,339.
6. Robinson, M. J., and Svedres, E. V. (1957), Sustained-release pharmaceutical preparations, U.S. Patent 2805977.
7. Sjögren, J., and Fryklöf, L-E. (1960), Duretter-A new type of oral sustained action preparation, Farmacevtisk Revy., 59, 171-179.
8. Sjögren, J. (1971), Studies on a sustained release principle based on inert plastic matrix, Acta Pharm. Suecica., 8, 153-168.
9. Speers, M., and Bonnano, C. (1999), Economic aspects of controlled drug delivery, in (Mathiowitz, E., Ed.), E ncyclopedia of Controlled Drug Delivery, Wiley, New York, pp. 341-347.
10. Cole, G., Hogan, J., and Aulton, M., Eds. (1995), Pharmaceutical Coating Technology, Taylor & Francis, London, 1995.
11. Ragnarsson, G., and Johansson, M. O. (1988), Coated drug cores in multiple unit preparations. Influence of particle size, Drug Dev. Ind. Pharm.., 14, 2285-2297.
12. Chatlapalli, R., and Rohera, B. D. (1998), Physical characterization of HPMC and HEC and investigation of their use as pelletization aids. Int. J. Pharm., 161, 179-193.
13. Kojima, M., and N akagami, H. (2002), Development of controlled release matrix pellets by annealing with micronized water-insoluble or enteric polymers, J. Controlled Release, 82, 335-343.
14. Young, C. R., Dietzsch, C., Cerea, M., Farrell, T., Fegely, K. A., Rajabi-Siahboomi, A., and McGinity, J. W. (2005), Physicochemical characterization and mechanisms of release of theophylline from melt-extruded dosage forms based on a methacrylic acid copolymer, Int. J. Pharm.., 301, 112-120.
15. Neau, S. H., Chow, M. Y., and Durrani, M. J. (1996), Fabrication and characterization of extruded and spheronized beads containing Carbopol 974P, NF resin, Int. J. Pharm.., 131, 47-55.
16. Bommareddy, G. S., Paker-Leggs, S., Saripella, K. K., and Neau, S. H. (2006), Extruded and spheronized beads containing Carbopol 974P to deliver nonelectrolytes and salts of weakly basic drugs, Int. J. Pharm.., 321, 62-71.
17. Abrahamsson, B., Alpsten, M., Jonssononsson, U. E., Lundberg, P. J., Sandberg, A., Sundgren, M., Svenheden, A., and Toelli, J. (1996), Gastro-intestinal transit of a multiple-unit formulation (metoprolol CR/ZOK) and a non-disintegrating tablet with the emphasis on colon, Int. J. Pharm.., 140, 229-235.
18. Thrombre, A. G. (2005), Assessment of feasibility of oral controlled release in an exploratory development setting, Drug Discov. Today., 10, 1159-1166.
19. Li, S., He, H., Parthiban, L. J., Yin, H., and Serajuddin, A. T. M. (2005), IV-IVC considerations in the development of immediate-release oral dosage form, J. Pharm. Sci.., 94, 1396-1417.
20. Noyes, A. A., and Whitney, W. R. (1897), The rate of solution of solid substances in their own solutions, J. Am. Chem. Soc.., 19, 930-934.
21. Dokoumetzidis, A., and Macheras, P. (2006), A century of dissolution research: From Noyes and Whitney to the Biopharmaceutics Classification System, Int. J. Pharm.., 321, 1-11.
22. Mooney, K. G., Mintun, M. A., Himmelstein, K. J., and Stella, V. J. (1981), Dissolution kinetics of carboxylic acids. I: Effect of pH under unbuffered conditions, J. Pharm. Sci.., 70, 13-22.
23. Mooney, K. G., Mintun, M. A., Himmelstein, K. J., and Stella, V. J. (1981), Dissolution kinetics of carboxylic acids. II: Effects of buffers, J. Pharm. Sci.., 70, 22-32.
24. Li, C. L., Martini, L. G., Ford, J. L., and Roberts, M. (2005), The use of hypromellose in oral drug delivery, J. Pharm. Pharmacol.., 57, 533-546.
25. Tatavarti, A. S., and Hoag, S. W. (2006), Microenvironmental pH modulation based release enhancement of a weakly basic drug from hydrophilic matrices, J. Pharm. Sci.., 95, 1459-1468.
26. Riis, T., Bauer-Brandl, A., Wagner, T., and Krantz, H. (2007), pH-independent drug release of an extremely poorly soluble weakly basic acidic drug from multiparticulate extended release formulations, Eur. J. Pharm. Biopharm.., 65, 78-84.
27. Streubel, A., Siepmann, J., Dashevsky, A., and Bodmeier, R. (2000), pH-independent release of a weakly basic drug from water-insoluble and-soluble matrix tablets, J. Controlled Release., 67, 101-110.
28. U.S. Food and Drug Administration (FDA) (2006), available: http://www.fda.gov.search.html.
29. Higuchi, T. (1963), Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices, J. Pharm. Sci., 52, 1145-1149.
30. Wu, X. S. (1996), Controlled Drug Delivery Systems, Technology Publishing, Lancaster, PA.
31. Jannin, V., Pochard, E., and Chambin, O. (2006), Influence of poloxamers on the dissolution performance and stability of controlled-release formulations containing Precirol ATO 5, Int. J. Pharm.., 309, 6-15.
32. Sinchaipanid, N., Junyaprasert, V., and Mitrevej, A. (2004), Application of hot-melt coating for controlled release of propranolol hydrochloride pellets, Powder Technol.., 141, 203-209.
33. Rodriguez, L., Caputo, O., Cini, M., Cavallari, C., and Greechi, R. (1993), In vitro release of theophylline from directly-compressed matrixes containing methacrylic acid copolymers and/or dicalcium phosphate dihydrate, Farmaco., 48, 1597-1604.
34. Ceballos, A., Cirri, M., Maestrelli, F., Corti, G., and Mura, P. (2005), Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets, Farmaco., 60, 913-918.
35. Oezyazici, M., Goekce, E. H., and E rtan, G. (2006), Release and diffusional modeling of metronidazole lipid matrices, Eur. J. Pharm. Biopharm.., 63, 331-339.
36. Hamdani, J., Moes, A. J., and A mighi, K. (2003), Physical and thermal characterization of Precirol and Compritol as lipophilic glycerides used for the preparation of controlled-release matrix pellets, Int. J. Pharm.., 260, 47-57.
37. U.S. Food and Drug Administration (FDA) (2006), available: http://www.accessdata.fda.gov/scripts/cder/iig/index.cfm.
38. Mehnert, W., and Mader, K. (2001), Solid lipid nanoparticles. Production, characterization and applications, Adv. Drug Deliv. Rev.., 47, 165-196.
39. Savolainen, M., Herder, J., Khoo, C., Lovqvist, K., Dahlqvist, C., Glad, H., and Juppo, A. M. (2003), Evaluation of polar lipid-hydrophilic polymer microparticles, Int. J. Pharm.., 262, 47-62.
40. Zhu, Y., Shah, N. H., Malick, A. W., Infeld, M. H., and McGinity, J. W. (2006), Controlled release of a poorly water-soluble drug from hot-melt extrudates containing acrylic polymers, Drug Dev. Ind. Pharm.., 32, 569-583.
41. Young, C. R., Dietzsch, C., and M cGinity, J. W. (2005), Compression of controlled-release pellets produced by a hot-melt extrusion and spheronization process, Pharm. Dev. Technol.., 10, 133-139.
42. Young, C. R., Koleng, J. J., and McGinity, J. W. (2002), Production of spherical pellets by a hot-melt extrusion and spheronization process, Int. J. Pharm.., 242, 87-92.
43. Hogan, J. E. (1995), Modified release coatings for pharmaceutics, in Cole, G., Hogan, J., and Aulton, M., Eds., Pharmaceutical Coating Technology, pp. 409-438.
44. Edgar, K. J., Buchanan, C. M., Debenham, J. S., Rundquist, P. A., Seiler, B. D., Shelton, M. C., and Tindall, D. (2001), Advances in cellulose ester performance and application, Prog. Polym. Sci.., 26, 1605-1688.
45. Hjärtstam, J. (1998), Ethyl Cellulose Membranes Used in Modified Release Formulations, Chalmers University of Technology, Göteborg, Sweden.
46. Savastano, L., Leuenberger, H., and Merkle, H. P. (1995), Membrane modulated dissolution of oral drug delivery systems, Pharm. Acta Helv.., 70, 117-124.
47. Theeuwes, F. (1975), Elementary osmotic pumps, J. Pharm. Sci.., 64, 147-157.
48. Ragnarsson, G., Sandberg, A., Johansson, M. O., Lindstedt, B., and Sjoegren, J. (1992), In vitro release characteristics of a membrane-coated pellet formulation. Influence of drug solubility and particle size, Int. J. Ph+arm.., 79, 223-232.
49. Ragnarsson, G., Sandberg, A., Jonsson, U. E., and Sjoegren, J. (1987), Development of a new controlled release metoprolol product, Drug Dev. Ind. Pharm.., 13, 1495-1509.
50. Kedem, O., and Katchalsky, A. (1961), J. Gen. Phys, 45, 143.
51. Kedem, O., and Katchalsky, A. (1958), Biochem. Biophys. Acta, 27, 229.
52. Verma, R. K., Krishna, D. M., and Garg, S. (2002), Formulation aspects in the development of osmotically controlled oral drug delivery systems, J. Controlled Release., 79, 7-27.
53. Elchidana, P. A., and Deshpande, S. G. (1999), Microporous membrane drug delivery system for indomethacin, J. Controlled Release., 59, 279-285.
54. Sousa, J. J., Sousa, A., Moura, M. J., Podczeck, F., and Newton, J. M. (2002), The influence of core materials and film coating on the drug release from coated pellets, Int. J. Pharm.., 233, 111-122.
55. Husson, I., Leclerc, B., Spenlehauer, G., Veillard, M., and Couarraze, G. (1991), Modeling of drug release from pellets coated with an insoluble polymeric membrane, J. Controlled Release., 17, 163-173.
56. Tang, E. S. K., Chan, L. W., and Heng, P. W. S. (2005), Coating of multiparticulates for sustained release, Am. J. Drug Deliv.., 3, 17-28.
57. Verma, R. K., Kaushal, A. M., and Garg, S. (2003), Development and evaluation of extended release formulations of isosorbide mononitrate based on osmotic technology, Int. J. Pharm.., 263, 9-24.
58. Ravishankar, H., Patil, P., Petereit, H-U., and Renner, G. (2005), EUDRAMODE: A novel approach to sustained oral drug delivery systems, Drug Deliv. Technol., 5, 48-50, 52-55.
59. Ravishankar, H., Iyer-Chavan, J., Patil, P., Samel, A., and Renner, G. (2006), Clinical studies of terbutaline controlled-release formulation prepared using EUDRAMODE, Drug Deliv. Technol.., 6, 50-56.
60. Kibbe, A. H. (2000), Handbook of Pharmaceutical Excipients, Pharmaceutical, London.
61. Aulton, M. E., and Twitchell, A. M. (1995), Solution properties and atomization in film coating [of pharmaceuticals], Pharm. Coat. Technol., 64-117.
62. Glatt (2006), available: www.glatt.com.
63. Harris, M. R., and Ghebre-Sellassie, I. (1989), Aqueous polymeric coating for modified-release pellets, Drugs Pharm. Sci.., 36, 63-79.
64. Colombo, P., Bettini, R., Santi, P., and P eppas, N. A. (2000), Swellable matrixes for controlled drug delivery: Gel-layer behavior, mechanisms and optimal performance, Pharm. Sci. Technol. Today., 3, 198-204.
65. Lapidus, H., and Lordi, N. G. (1966), Some factors affecting the release of a water-soluble drug from a compressed hydrophilic matrix, J. Pharm. Sci., 55, 840-843.
66. Lapidus, H., and Lordi, N. G. (1968), Drug release from compressed hydrophilic matrixes, J. Pharm. Sci.., 57, 1292-1301.
67. Huber, H. E., Dale, L. B., and Christenson, G. L. (1966), Utilization of hydrophilic gums for the control of drug release from tablet formulations. I. Disintegration and dissolution behavior, J. Pharm. Sci.., 55, 974-976.
68. Koerner, A., Larsson, A., Piculell, L., and Wittgren, B. (2005), Tuning the polymer release from hydrophilic matrix tablets by mixing short and long matrix polymers, J. Pharm. Sci.., 94, 759-769.
69. Ju, R. T. C., Nixon, P. R., and Patel, M. V. (1995), Drug release from hydrophilic matrixes 1. New scaling laws for predicting polymer and drug release based on the polymer disentanglement concentration and the diffusion layer, J. Pharm. Sci.., 84, 1455-1463.
70. Ju, R. T. C., Nixon, P. R., Patel, M. V., and Tong, D. M. (1995), Drug release from hydrophilic matrixes. 2. A mathematical model based on the polymer disentanglement concentration and the diffusion layer, J. Pharm. Sci.., 84, 1464-1477.
71. Bettini, R., Colombo, P., Massimo, G., Catellani, P. L., and Vitali, T. (1994), Swelling and drug release in hydrogel matrixes: Polymer viscosity and matrix porosity effects, Eur. J. Pharm. Sci.., 2, 213-219.
72. Adler, J., Jayan, A., and Melia, C. D. (1999), A method for quantifying differential expansion within hydrating hydrophilic matrixes by tracking embedded fluorescent microspheres, J. Pharm. Sci.., 88, 371-377.
73. Treloar, L. R. G. (1975), The Physics of Rubber Elasticity, Clarendon, Oxford.
74. Siepmann, J., Kranz, H., Bodmeier, R., and Peppas, N. A. (1999), HPMC-matrices for controlled drug delivery: A new model combining diffusion, swelling, and dissolution mechanisms and predicting the release kinetics, Pharm. Res.., 16, 1748-1756.
75. Colombo, P., Bettini, R., Massimo, G., Catellani, P. L., Santi, P., and Peppas, N. A. (1995), Drug diffusion front movement is important in drug release control from swellable matrix tablets, J. Pharm. Sci.., 84, 991-997.
76. Bettini, R., Catellani, P. L., Santi, P., Massimo, G., Peppas, N. A., and Colombo, P. (2001), Translocation of drug particles in HPMC matrix gel layer: Effect of drug solubility and influence on release rate, J. Controlled Release., 70, 383-391.
77. Fu, X. C., Liang, W. Q., and Ma, X. W. (2003), Relationships between the release of soluble drugs from HPMC matrices and the physicochemical properties of drugs, Pharmazie., 58, 221-222.
78. Tahara, K., Yamamoto, K., and Nishihata, T. (1996), Application of model-independent and model analysis for the investigation of effect of drug solubility on its release rate from hydroxypropyl methyl cellulose sustained-release tablets, Int. J. Pharm.., 133, 17-27.
79. Korsmeyer, R. W., Gurny, R., Doelker, E., Buri, P., and Peppas, N. A. (1983), Mechanisms of solute release from porous hydrophilic polymers, Int. J. Pharm.., 15, 25-35.
80. Rinaki, E., Valsami, G., and Macheras, P. (2003), The power law can describe the " entire " drug release curve from HPMC-based matrix tablets: A hypothesis, Int. J. Pharm.., 255, 199-207.
81. Ritger, P. L., and Peppas, N. A. (1987), A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices, J. Controlled Release., 5, 37-42.
82. Ritger, P. L., and Peppas, N. A. (1987), A simple equation for description of solute release. I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or disks, J. Controlled Release., 5, 23-36.
83. Siepmann, J., and Peppas, N. A. (2001), Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC), Adv. Drug Deliv. Rev., 48, 139-157.
84. Peppas, N. A., and Sahlin, J. J. (1989), A simple equation for the description of solute release. III. Coupling of diffusion and relaxation, Int. J. Pharm.., 57, 169-72.
85. Gao, P., and Meury, R. H. (1996), Swelling of hydroxypropyl methylcellulose matrix tablets. 1. Characterization of swelling using a novel optical imaging method, J. Pharm. Sci.., 85, 725-731.
86. Mitchell, K., Ford, J. L., Armstrong, D. J., Elliott, P. N. C., Hogan, J. E., and Rostron, C. (1993), The influence of substitution type on the performance of methyl cellulose and hydroxypropyl methyl cellulose in gels and matrixes, Int. J. Pharm., 100, 143-154.
87. Levina, M., and Rajabi-Siahboomi, A. R. (2004), The influence of excipients on drug release from hydroxypropyl methylcellulose matrices, J. Pharm. Sci.., 93, 2746-2754.
88. Ford, J. L., Rubinstein, M. H., and Hogan, J. E. (1985), Propranolol hydrochloride and aminophylline release from matrix tablets containing hydroxypropyl methyl cellulose, Int. J. Pharm., 24, 339-350
89. Ford, J. L., Rubinstein, M. H., and Hogan, J. E. (1985), Formulation of sustained-release promethazine hydrochloride tablets using hydroxypropyl methyl cellulose matrixes, Int. J. Pharm.., 24, 327-338.
90. Reynolds, T. D., Mitchell, S. A., and Balwinski, K. M. (2002), Investigation of the effect of tablet surface area/volume on drug release from hydroxypropyl methylcellulose controlled-release matrix tablets, Drug Dev. Ind. Pharm.., 28, 457-466.
91. Skoug, J. W., Borin, M. T., Fleishaker, J. C., and Cooper, A. M. (1991), In vitro and in vivo evaluation of whole and half tablets of sustained-release adinazolam mesylate, Pharm. Res.., 8, 1482-1488.
92. Sung, K. C., Nixon, P. R., Skoug, J. W., Ju, T. R., Gao, P., Topp, E. M., and P atel, M. V. (1996), Effect of formulation variables on drug and polymer release from HPMC-based matrix tablets, Int. J. Pharm.., 142, 53-60.
93. Ford, J. L., Rubinstein, M. H., McCaul, F., Hogan, J. E., and Edgar, P. J. (1987), Importance of drug type, tablet shape and added diluents on drug release kinetics from hydroxypropyl methyl cellulose matrix tablets, Int. J. Pharm.., 40, 223-234.
94. Heng, P. W., Chan, L. W., Easterbrook, M. G., and L i, X. (2001), I nvestigation of the influence of mean HPMC particle size and number of polymer particles on the release of aspirin from swellable hydrophilic matrix tablets, J. Controlled Release., 76, 39-49.
95. Velasco, M. V., and Ford, J. L., Rowe, P., and R ajabi-Siahhoomi, A. R. (1999), Influence of drug: Hydroxypropyl methyl cellulose ratio, drug and polymer particle size and compression force on the release of diclofenac sodium from HPMC tablets, J. Controlled Release., 57, 75-85.
96. Dabbagh, M. A., Ford, J. L., Rubinstein, M. H., and Hogan, J. E. (1996), Effects of polymer particle size, compaction pressure and hydrophilic polymers on drug release from matrixes containing ethyl cellulose, Int. J. Pharm.., 140, 85-95.
97. Mitchell, K., Ford, J. L., Armstrong, D. J., Elliott, P. N. C., Hogan, J. E., and Rostron, C. (1993), The influence of the particle size of hydroxypropyl methyl cellulose K15M on its hydration and performance in matrix tablets, Int. J. Pharm.., 100, 175-179.
98. Sheskey, P. J., Cabelka, T. D., Robb, R. T., and Boyce, B. M. (1994), Use of roller compaction in the preparation of controlled-release hydrophilic matrix tablets containing methyl cellulose and hydroxypropyl methyl cellulose polymers, Pharm. Technol., 18, 132, 134, 136, 138, 140, 142, 144., 146, 148-150.
99. Sheskey, P. J., and Hendren, J. (1999), The effects of roll compaction equipment variables, granulation technique, and HPMC polymer level on a controlled-release matrix model drug formulation, Pharm. Technol., 23, 90, 92, 94, 96, 98, 100, 102, 104, 106.
100. Sheskey, P., Pacholke, K., Sackett, G., Maher, L., and Polli, J. (2000), Effect of process scale-up on robustness of tablets, tablet stability, and predicted in vivo performance, Pharm. Technol., 24, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52.
101. Timmins, P., Delargy, A. M., Howard, J. R., and Rowlands, E. A. (1991), Evaluation of the granulation of a hydrophilic matrix sustained-release tablet, Drug Dev. Ind. Pharm.., 17, 531-550.
102. Liu, C. H., Chen, S. C., Kao, Y. H., Kao, C. C., Sokoloski, T. D., and Sheu, M. T. (1993), Properties of hydroxypropyl methyl cellulose granules produced by water spraying, Int. J. Pharm.., 100, 241-248.
103. Herder, J., Adolfsson, A., and Larsson, A. (2006), Initial studies of water granulation of eight grades of hypromellose (HPMC), Int. J. Pharm.., 313, 57-65.
104. Dahl, T. C., and Bormeth, A. P. (1990), Naproxen controlled release matrix tablets: Fluid bed granulation feasibility, Drug Dev. Ind. Pharm.., 16, 581-590.
105. Nellore, R. V., Rekhi, G. S., Hussain, A. S., Tillman, L. G., and Augsburger, L. L. (1998), Development of metoprolol tartrate extended-release matrix tablet formulations for regulatory policy consideration, J. Controlled Release., 50, 247-256.
106. Liu, C. H., Kao, Y. H., Chen, S. C., Sokoloski, T. D., and Sheu, M. T. (1995), In-vitro and in-vivo studies of the diclofenac sodium controlled-release matrix tablets, J. Pharm. Pharmacol.., 47, 360-364.
107. Dahl, T. C., Calderwood, T., Bormeth, A., Trimble, K., and Piepmeier, E. (1990), Influence of physicochemical properties of hydroxypropyl methyl cellulose on naproxen release from sustained release matrix tablets, J. Controlled Release., 14, 1-10.
108. Shah, N. H., Railkar, A. S., Phuapradit, W., Zeng, F. W., Chen, A., Infeld, M. H., and Malick, A. W. (1996), Effect of processing techniques in controlling the release rate and mechanical strength of hydroxypropyl methyl cellulose based hydrogel matrixes, Eur. J. Pharm. Biopharm.., 42, 183-187.
109. Sheskey, P. J., and Keary, C. M. (2002), Aqueous air foams, U.S. Patent 7011702.
110. Keary, C. M., and Sheskey, P. J. (2004), Preliminary report of the discovery of a new pharmaceutical granulation process using foamed aqueous binders, Drug Dev. Ind. Pharm.., 30, 831-845.
111. Cao, Q-R., Choi, Y-W., Cui, J-H., and Lee, B-J. (2005), Effect of solvents on physical properties and release characteristics of monolithic hydroxypropylmethylcellulose matrix granules and tablets, Arch. Pharm. Res.., 28, 493-501.
112. Sheskey, P. J., and Williams, D. M. (1996), Comparison of low-shear and high-shear wet granulation techniques and the influence of percent water addition in the preparation of a controlled-release matrix tablet containing HPMC and a high-dose, highly water-soluble drug, Pharm. Technol., 20, 80, 82, 84, 86, 88, 90, 92.
113. Zhang, F., and McGinity, J. W. (1999), Properties of sustained-release tablets prepared by hot-melt extrusion, Pharm. Dev. Technol.., 4, 241-250.
114. Urbano, A. P. A., Ribeiro, A. J., and Veiga, F. (2006), Design of pectin beads for oral protein delivery, Chem. Ind. Chem. Eng. Q.., 12, 24-30.
115. Fukuda, M., Peppas, N. A., and McGinity, J. W. (2006), Properties of sustained release hot-melt extruded tablets containing chitosan and xanthan gum, Int. J. Pharm.., 310, 90-100.
116. De Brabander, C., Vervaet, C., and Remon, J. P. (2003), Development and evaluation of sustained release mini-matrices prepared via hot melt extrusion, J. Controlled Release., 89, 235-247.
117. Baumgartner, S., Slamersek, V., and Kristl, J. (2003), Controlled drug delivery of hydrophilic drugs from cellulose ether matrix tablets: The influence of the drug molecule size on its release mechanism and kinetics, Farm. Vestnik (Ljubljana, Slov.)., 54, 359-360.
118. Genc, L., Bilac, H., and Guler, E. (1999), Studies on controlled release dimenhydrinate from matrix tablet formulations, Pharm. Acta Helv.., 74, 43-49.
119. Sinha Roy, D., and Rohera Bhagwan, D. (2002), Comparative evaluation of rate of hydration and matrix erosion of HEC and HPC and study of drug release from their matrices, Eur. J. Pharm. Sci.., 16, 193-199.
120. Vueba, M. L., Batista de Carvalho, L. A. E., Veiga, F., Sousa, J. J., and Pina, M. E. (2006), Influence of cellulose ether mixtures on ibuprofen release: MC25, HPC and HPMC K100M, Pharm. Dev. Technol.., 11, 213-228.
121. Vueba, M. L., Batista De Carvalho, L. A. E., Veiga, F., Sousa, J. J., and Pina, M. E. (2004), Influence of cellulose ether polymers on ketoprofen release from hydrophilic matrix tablets, Eur. J. Pharm. Biopharm.., 58, 51-59.
122. Talukdar, M. M., Michoel, A., Rombaut, P., and K inget, R. (1996), Comparative study on xanthan gum and hydroxypropyl methyl cellulose as matrixes for controlled-release drug delivery I. Compaction and in vitro drug release behavior, Int. J. Pharm.., 129, 233-241.
123. Talukdar, M. M., and Kinget, R. (1997), Comparative study on xanthan gum and hydroxypropyl methyl cellulose as matrixes for controlled-release drug delivery. II. Drug diffusion in hydrated matrixes, Int. J. Pharm.., 151, 99-107.
124. Andreopoulos, A. G., and Tarantili, P. A. (2002), Study of biopolymers as carriers for controlled release, J. Macromol. Sci. Phys., B41, 559-578.
125. Andreopoulos, A. G., and Tarantili, P. A. (2001), Xanthan gum as a carrier for controlled release of drugs, J. Biomater. Appl.., 16, 34-46.
126. Talukdar, M. M., Rombaut, P., and Kinget, R. (1998), The release mechanism of an oral controlled-release delivery system for indomethacin, Pharm. Dev. Technol.., 3, 1-6.
127. Talukdar, M. M., and Kinget, R. (1995), Swelling and drug release behavior of xanthan gum matrix tablets, Int. J. Pharm.., 120, 63-72.
128. Maggi, L., Segale, L., Torre, M. L., Ochoa Machiste, E., and Conte, U. (2002), Dissolution behaviour of hydrophilic matrix tablets containing two different polyethylene oxides (PEOs) for the controlled release of a water-soluble drug. Dimensionality study, Biomaterials., 23, 1113-1119.
129. Choulis, N., and Papadopoulos, H. (1975), Timed-release tablets containing quinine sulfate, J. Pharm. Sci.., 64, 1033-1035.
130. Huang, L-L., and Schwartz, J. B. (1995), Studies on drug release from a carbomer tablet matrix, Drug Dev. Ind. Pharm.., 21, 1487-1501.
131. El-Sayed, G. M., El-Said, Y., Meshali, M. M., and Schwartz, J. B. (1996), Kinetics of theophylline release from different tablet matrixes, STP Pharma Sci.., 6, 390-397.
132. Patel, G. N., Patel, G. C., Patel, R. B., Patel, S. S., Patel, J. K., Bharadia, P. D., and Patel, M. M. (2006), Oral colon-specific drug delivery: An overview, Drug Deliv. Technol.., 6, 62-71.
133. Liu, L. S., Fishman, M. L., Kost, J., and Hicks, K. B. (2003), Pectin-based systems for colon-specific drug delivery via oral route, Biomaterials., 24, 3333-3343.
134. Liew, C. V., Chan, L. W., Ching, A. L., and Heng, P. W. S. (2006), Evaluation of sodium alginate as drug release modifier in matrix tablets, Int. J. Pharm.., 309, 25-37.
135. Shilpa, A., Agrawal, S. S., and Ray, A. R. (2003), Controlled delivery of drugs from alginate matrix, J. Macromol. Sci. Polym. Rev., C43, 187-221.
136. Ostberg, T., and Graffner, C. (1994), Calcium alginate matrixes for oral multiple unit administration: III. Influence of calcium concentration, amount of drug added and alginate characteristics on drug release, Int. J. Pharm.., 111, 271-282.
137. Varma, M. V. S., Kaushal, A. M., Garg, A., and Garg, S. (2004), Factors affecting mechanism and kinetics of drug release from matrix-based oral controlled drug delivery systems, Am. J. Drug Deliv.., 2, 43-57.
138. McCall, T. W., Baichwal, A. R., and Staniforth, J. N. (2003), TIMERx oral controlled-release drug delivery system, Drugs Pharm. Sci.., 126, 11-19.
139. Friend, D. R. (2005), New oral delivery systems for treatment of inflammatory bowel disease, Adv. Drug Deliv. Rev.., 57, 247-265.
140. Ghandehari, H., Kopeckova, P., and Kopecek, J. (1997), In vitro degradation of pH-sensitive hydrogels containing aromatic azo bonds, Biomaterials., 18, 861-872.
141. Akala, E. O., Kopeckova, P., and Kopecek, J. (1998), Novel pH-sensitive hydrogels with adjustable swelling kinetics, Biomaterials., 19, 1037-1047.
142. Takka, S., Rajbhandari, S., and Sakr, A. (2001), Effect of anionic polymers on the release of propranolol hydrochloride from matrix tablets, Eur. J. Pharm. Biopharm.., 52, 75-82.
143. Nie, S., Pan, W., Li, X., and Wu, X. (2004), The effect of citric acid added to hydroxypropyl methylcellulose (HPMC) matrix tablets on the release profile of vinpocetine, Drug Dev. Ind. Pharm.., 30, 627-635.
144. Varma, M. V. S., Kaushal, A. M., and Garg, S. (2005), Influence of micro-environmental pH on the gel layer behavior and release of a basic drug from various hydrophilic matrices, J. Controlled Release., 103, 499-510.
145. Qiu, Y., and Park, K. (2001), Environment-sensitive hydrogels for drug delivery, Adv. Drug Deliv. Rev.., 53, 321-339.
146. Bromberg, L. (2005), Intelligent hydrogels for the oral delivery of chemotherapeutics, Exp. Opin. Drug Deliv.., 2, 1003-1013.
147. Rowe, C. W., Wang, C-C., and Monkhouse, D. C. (2003), TheriForm technology, D rugs Pharm. Sci.., 126, 77-87.
148. Lee, K-J., Kang, A., Delfino, J. J., West, T. G., Chetty, D., Monkhouse, D. C., and Yoo, J. (2003), Evaluation of critical formulation factors in the development of a rapidly dispersing captopril oral dosage form, Drug Dev. Ind. Pharm.., 29, 967-979.
149. Rocca, J. G., and Park, K. (2004), Oral drug delivery: Prospects & challenges, Drug Deliv. Technol., 4, 52-54, 57.